NIH GUIDE, Volume 22, Number 29, August 13, 1993


P.T. 34


  Dosage Forms+ 

  Chemistry, Analytical 

  Chemistry, Organic 

National Institute on Drug Abuse

The National Institute on Drug Abuse (NIDA) is soliciting proposals

from qualified organizations to: develop and produce dosage forms of

cannabinoids and other drugs used in basic and clinical research

programs; analyze such preparations and cannabis samples for

cannabinoid content; and maintain supply and shipment records of

these and other research materials.  The work may include the

manufacture of sterile parenterals, marijuana cigarettes, oral dosage

forms, morphine pellets, and other dosage forms as needed; the

preparation of analytical standards; and the performance of in vitro

smoking studies.  Drug Enforcement Administration registrations for

manufacturing, distribution, importation, and exportation of Schedule

I and II drugs are required.  It is anticipated that a five-year

incrementally funded contract will be awarded.  Estimated issuance

date of RFP No. N01DA-4-7403 is August 12, 1993, and responses are

due to be received in the Contracting Office 45 calendar days

thereafter.  This is a follow-on procurement to Contract No.

271-90-7301 with Research Triangle Institute.


Only written or facsimile requests for this RFP will be accepted.

Forward all requests to:

Ms. Carol Cushing, Contract Specialist

National Institute on Drug Abuse

Parklawn Building, Room 10-49

5600 Fishers Lane

Rockville, MD  20857

FAX:  (301) 443-7595


Return to 1993 Index

Return to NIH Guide Main Index

Office of Extramural Research (OER) - Home Page Office of Extramural
Research (OER)
  National Institutes of Health (NIH) - Home Page National Institutes of Health (NIH)
9000 Rockville Pike
Bethesda, Maryland 20892
  Department of Health and Human Services (HHS) - Home Page Department of Health
and Human Services (HHS) - Government Made Easy

Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.